101 related articles for article (PubMed ID: 12783171)
1. Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores.
Brossner C; Winterholer A; Roehlich M; Dlouhy-Schütz E; Serra V; Sonnleithner M; Grubmüller KH; Pummer K; Schuster E
World J Urol; 2003 Aug; 21(3):163-6. PubMed ID: 12783171
[TBL] [Abstract][Full Text] [Related]
2. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
3. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
4. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
5. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
6. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.
Keetch DW; Catalona WJ
J Urol; 1995 Nov; 154(5):1795-7. PubMed ID: 7563349
[TBL] [Abstract][Full Text] [Related]
7. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.
Kawakami S; Kihara K; Fujii Y; Masuda H; Kobayashi T; Kageyama Y
Int J Urol; 2004 Aug; 11(8):613-8. PubMed ID: 15285751
[TBL] [Abstract][Full Text] [Related]
8. Importance of transition zone prostate biopsies in patients with gray-zone PSA levels undergoing the ultrasound-guided systematic ten-biopsy regimen for the first time.
Ishizuka O; Mimura Y; Oguchi T; Kawakami M; Nishizawa O
Urol Int; 2005; 74(1):23-6. PubMed ID: 15711104
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
10. [Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
Perdonà S; De Sio M; Damiano R; Oliva A; D'Armiento M
Arch Ital Urol Androl; 2000 Dec; 72(4):258-63. PubMed ID: 11221051
[TBL] [Abstract][Full Text] [Related]
11. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.
Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I
Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection.
Naughton CK; Miller DC; Mager DE; Ornstein DK; Catalona WJ
J Urol; 2000 Aug; 164(2):388-92. PubMed ID: 10893592
[TBL] [Abstract][Full Text] [Related]
13. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
[TBL] [Abstract][Full Text] [Related]
14. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases.
Fleshner N; Klotz L
Urology; 2002 Jul; 60(1):93-7. PubMed ID: 12100931
[TBL] [Abstract][Full Text] [Related]
15. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
16. Extensive biopsy protocol improves the detection rate of prostate cancer.
Ravery V; Goldblatt L; Royer B; Blanc E; Toublanc M; Boccon-Gibod L
J Urol; 2000 Aug; 164(2):393-6. PubMed ID: 10893593
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
[TBL] [Abstract][Full Text] [Related]
18. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men.
Matsumoto K; Satoh T; Egawa S; Shimura S; Kuwao S; Baba S
Int J Urol; 2005 Apr; 12(4):353-60. PubMed ID: 15948721
[TBL] [Abstract][Full Text] [Related]
20. Cancer diagnosis with prostate specific antigen greater than 10 ng./ml. and negative peripheral zone prostate biopsy.
Fowler JE; Condon MA; Terrell FL
J Urol; 1996 Oct; 156(4):1370-4. PubMed ID: 8808874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
